Accueil>>Signaling Pathways>> Others>>Nitracrine

Nitracrine

Catalog No.GC33400

La nitracrine inhibe la synthèse d'ARN et se lie de manière covalente et réversible À l'ADN, mais forme également des adduits covalents avec l'ADN in vivo. La nitracrine, un dérivé de la 1-nitroacridine, est un puissant agent sélectif de l'hypoxie in vitro et un médicament antitumoral. La nitracrine a une cytotoxicité envers la plupart des cellules.

Products are for research use only. Not for human use. We do not sell to patients.

Nitracrine Chemical Structure

Cas No.: 4533-39-5

Taille Prix Stock Qté
1mg
368,00 $US
En stock
5mg
735,00 $US
En stock
10mg
1 250,00 $US
En stock
20mg
2 206,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Nitracrine is an antitumor drug that has been used clinically for several years.

It is demonstrated during the reduction of ledakrin that a key metabolite, a compound with anadditional five-membered ring attaching to positions 1 and 9 of the acridine core and with the retained 9-aminoalkyl side chain, is formed in all the systems that are studied. It is determined that the reactive nitrogen atoms of this additional ring undergo further transformations resulting in the formation of a six-membered ring produced by the addition of a carbon atom to the dihydropyrazoloacridine ring. Furthermore, it is observed that positions 2 and 4 of ledakrin's acridine ring are susceptible to nucleophilic substitution as revealing by the studies with dithiothreitol. Additionally, although most products from the reduction of ledakrin are extremely unstable, 1-aminoacridinone, producing enzymatically and with dithiothreitol, exhibiting persistent stability under the studied conditions[1].

[1]. Gorlewska K, et al. Products of metabolic activation of the antitumor drug ledakrin (nitracrine) in vitro.

Avis

Review for Nitracrine

Average Rating: 5 ★★★★★ (Based on Reviews and 13 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Nitracrine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.